Dietary Supplement Contract Manufacturers in USA — CSK Biotech CDMO Solutions
CSK Biotech delivers enterprise-grade contract development and manufacturing for brands seeking dietary supplement contract manufacturers in usa — a single-source CDMO that pairs GMP-certified facilities with R&D-led formulation and turnkey packaging to help you launch quality softgels, tablets, powders, gummies, and liquids with speed and regulatory confidence.
Why CSK Biotech matters for CSK Biotech
Choosing the right nutritional supplements manufacturer is more than a procurement decision; it’s a strategic partnership that affects product safety, market timing, and brand reputation. Founded in 2008, CSK Biotech has grown into a high‑tech enterprise focused on the R&D and manufacturing of dietary supplements, health foods, and cosmetics. Our GMP-certified 2,000㎡ factory and seven advanced production lines support an annual capacity that exceeds 4.5 billion softgels and 1.5 billion tablets, enabling both startups and established brands to scale without sacrificing quality.
We design manufacturing processes with brand objectives in mind: consistency for repeatable dosing, manufacturing tolerance that preserves bioavailability, and stability verification so finished goods meet shelf-life targets. For buyers, that translates into fewer production surprises, predictable lead times, and the documentation required for global regulatory submissions.
Flexible formats, end-to-end services
CSK Biotech offers a full spectrum of manufacturing formats and lifecycle services that reduce the operational burden on your team. Whether you need private-label runs or a fully custom formulation, our CDMO model supports three cooperation pathways to match your commercial strategy:
- ODM — Market-oriented product innovation and rapid-to-market formula concepts, ideal for brands needing ready-to-launch SKUs.
- CDM — Tailor-made product design based on market briefs, ingredient selection, and performance targets.
- OEM — Precise, formula-based production when you supply the specification and expect exact replication at scale.
Core manufacturing capabilities include capsules, tablets, powders, gummies, liquid suspensions and syrups, plus specialist softgel lines. Complementary services—formulation R&D, pilot testing, stability studies, regulatory registration support, and free packaging design—mean CSK Biotech handles the product journey from concept through launch. This turnkey approach reduces coordination overhead and accelerates time-to-shelf while maintaining traceability and quality control at every step.
Quality, compliance and partnership transparency
Quality assurance is built into CSK Biotech’s operations. Certified by GMPC, FDA, HACCP, and ISO standards, our systems emphasize raw-material traceability, in-line process controls, and finished-product testing. These certifications reflect consistent audit-readiness and adherence to internationally recognized safety practices—critical for brands selling in regulated markets.
Beyond certificates, our partnership philosophy emphasizes clear project milestones, proactive communication, and predictable logistics. Typical engagements include pilot batches and stability verification before full production, documented quality agreements, and support for regulatory dossiers. For international clients, we also provide guidance on labeling, import documentation, and supply-chain resilience. Reach us at https://www.cskbiotech.com/ or steve@cskbiotech.com to discuss capacities, samples, or custom formulation needs.
FAQ
What minimum order quantities (MOQs) should I expect when working with CSK Biotech?
MOQs vary by format and complexity. Typical MOQs are lower for standard private-label products and higher for custom formulations and specialty softgels. CSK Biotech evaluates each project against production line set-up, ingredient sourcing, and regulatory testing to propose an MOQ that balances cost-efficiency and quality—contact steve@cskbiotech.com with your SKU details for a tailored estimate.
How long are lead times from formulation to finished goods?
Lead times depend on the engagement model. For ODM or existing formulas, pilot-to-production lead times can be as short as 8–12 weeks, subject to packaging and shipping. Fully custom CDM projects require additional R&D, pilot testing, and stability studies, typically extending timelines to 12–20 weeks. CSK Biotech provides a detailed project schedule during proposal so you can plan marketing and distribution milestones.
What certifications and quality controls does CSK Biotech maintain?
CSK Biotech operates under GMPC, FDA, HACCP, and ISO-certified systems. Our quality program includes raw-material verification, in-process controls, environmental monitoring, and finished-product testing. Documentation packages and batch records are available to support regulatory submissions and audit requirements for domestic and international markets.
Can CSK Biotech help with regulatory registration and labeling for US markets?
Yes. As a full-service CDMO, CSK Biotech supports regulatory registration workflows and provides documentation required for many jurisdictions, including ingredient specifications, stability data, and GMP compliance records. While final regulatory filings and claims are managed by the brand owner, we supply the technical dossiers and testing results needed to streamline registration and retailer approvals.
Do you offer assistance with packaging and marketing collateral for private-label products?
CSK Biotech offers free packaging services and marketing support as part of select cooperation models. Our team can provide artwork templates, secondary packaging options, and labeling guidance aligned with regulatory requirements. For brands seeking additional creative services, we coordinate with design partners to accelerate launch-ready packaging that meets retailer and e‑commerce standards.
Contact
cskmanufacture
CSK Biotech Dietary Supplements
Guangzhou Changshengkang Biotechnology Co.,Ltd